Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-01

Clinical Trial Update: Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated a chemoimmunotherapy regimen of rituximab, bendamustine, and mitoxantrone followed by rituximab in elderly patients with advanced, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bendamustine (Bendamustine)
  • Mitoxantrone (mitoxantrone)
  • Rituximab (rituximab)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Follicular Lymphoma | Phase 2 | Status: COMPLETED